NCT00773916View on ClinicalTrials.gov

The Role of Adverse Environment Factors, Family Functioning and Parental Psychopathology in the Response to Treatment With Methylphenidate in Children and Adolescents With Attention Deficit/Hyperactivity Disorder

PHASE4CompletedINTERVENTIONAL
Enrollment

130

Participants

Timeline

Start Date

March 31, 2006

Primary Completion Date

July 31, 2008

Study Completion Date

July 31, 2009

Conditions
Attention Deficit Disorder With Hyperactivity
Interventions
DRUG

Methylphenidate

Dose increments according to clinical evaluation, starting with 0,3 mg/kg of weight/day

Trial Locations (1)

90035-903

ADHD Outpatient Program - Hospital de Clínicas de Porto Alegre, Porto Alegre

All Listed Sponsors
collaborator

Conselho Nacional de Desenvolvimento Científico e Tecnológico

OTHER_GOV

collaborator

Hospital de Clinicas de Porto Alegre

OTHER

lead

Federal University of Rio Grande do Sul

OTHER

NCT00773916 - The Role of Adverse Environment Factors, Family Functioning and Parental Psychopathology in the Response to Treatment With Methylphenidate in Children and Adolescents With Attention Deficit/Hyperactivity Disorder | Biotech Hunter | Biotech Hunter